[Effect of propranolol on lidocaine pharmacokinetics]. 1990

G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
Z Zakładu Farmakologii Klinicznej PAM w Szczecinie.

The study aimed at investigating an effect of propranolol on lidocaine pharmacokinetic parameters, especially elimination rate and total clearance rate. The study was carried out in 8 rabbits with cross-over technique. The animals were examined twice. Sequence of therapy was established randomly. Some group of the animals were given propranolol and lidocaine first while the remaining animals were given lidocaine alone. Sequence of drugs administration was changed after one week. Propranolol was given in a single dose of 0.05 mg/kg b.w. intravenously. Lidocaine was injected in a single dose of 3 mg/kg b.w. during 5 minutes i.v. after a 30-minute interval. All drugs were injected into ear vein. Blood for assays was collected 8 times within 6 hours after lidocaine administration. TDx system manufactured by Abbott was used for drug concentration assay with immunofluorescence polarization method. One-compartment open model was used for calculations. The results were analysed with Student t-test for pairs. Significant decrease in AUC, marked decrease in distribution volume and total body clearance following lidocaine and propranolol were noted. The study has shown that there is interaction between propranolol and lidocaine leading to a decrease in total body lidocaine clearance.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
January 1990, European journal of clinical pharmacology,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
January 1983, Journal de pharmacologie,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
April 1977, The American journal of medicine,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
October 2005, European journal of anaesthesiology,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
September 2004, Basic & clinical pharmacology & toxicology,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
July 1981, Schweizerische medizinische Wochenschrift,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
May 1981, The New England journal of medicine,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
December 1986, Clinical pharmacy,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
March 1987, Archives internationales de pharmacodynamie et de therapie,
G Gawrońska-Szklarz, and P Bijoś, and J Feszak, and M Droździk, and K Goertz, and J Wójcicki
August 1990, Resuscitation,
Copied contents to your clipboard!